{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:07:20Z","timestamp":1793912840951,"version":"4.8.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Increasing evidence suggests that Parkinson\u2019s disease (PD) exhibits disparate spatial and temporal patterns of progression. Here we used a machine-learning technique\u2014Subtype and Stage Inference (SuStaIn) \u2014 to uncover PD subtypes with distinct trajectories of clinical and neurodegeneration events. We enrolled 228 PD patients and 119 healthy controls with comprehensive assessments of olfactory, autonomic, cognitive, sleep, and emotional function. The integrity of substantia nigra (SN), locus coeruleus (LC), amygdala, hippocampus, entorhinal cortex, and basal forebrain were assessed using diffusion and neuromelanin-sensitive MRI. SuStaIn model with above clinical and neuroimaging variables as input was conducted to identify PD subtypes. An independent dataset consisting of 153 PD patients and 67 healthy controls was utilized to validate our findings. We identified two distinct PD subtypes: subtype 1 with rapid eye movement sleep behavior disorder (RBD), autonomic dysfunction, and degeneration of the SN and LC as early manifestations, and cognitive impairment and limbic degeneration as advanced manifestations, while subtype 2 with hyposmia, cognitive impairment, and limbic degeneration as early manifestations, followed later by RBD and degeneration of the LC in advanced disease. Similar subtypes were shown in the validation dataset. Moreover, we found that subtype 1 had weaker levodopa response, more GBA mutations, and poorer prognosis than subtype 2. These findings provide new insights into the underlying disease biology and might be useful for personalized treatment for patients based on their subtype.<\/jats:p>","DOI":"10.1038\/s41531-023-00556-3","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T15:01:44Z","timestamp":1689260504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Two distinct trajectories of clinical and neurodegeneration events in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8025-5967","authenticated-orcid":false,"given":"Cheng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinChao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2313-4477","authenticated-orcid":false,"given":"Xiaojun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9092-7824","authenticated-orcid":false,"given":"Xueqin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengye","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0127-2812","authenticated-orcid":false,"given":"Xiaojun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8099-7407","authenticated-orcid":false,"given":"Baorong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0145-7558","authenticated-orcid":false,"given":"Minming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"556_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"556_CR2","doi-asserted-by":"publisher","unstructured":"Lee, S. H. et al. Parkinson\u2019s disease subtyping using clinical features and biomarkers: literature review and preliminary study of subtype clustering. Diagnostics 12 https:\/\/doi.org\/10.3390\/diagnostics12010112 (2022).","DOI":"10.3390\/diagnostics12010112"},{"key":"556_CR3","first-page":"349","volume":"17","author":"D Berg","year":"2021","unstructured":"Berg, D. et al. Prodromal Parkinson disease subtypes - key to understanding heterogeneity. Nature reviews. Neurology 17, 349\u2013361 (2021).","journal-title":"Neurology"},{"key":"556_CR4","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/acn3.51436","volume":"8","author":"PS Myers","year":"2021","unstructured":"Myers, P. S. et al. Distinct progression patterns across Parkinson disease clinical subtypes. Ann. Clin. Transl. Neurol. 8, 1695\u20131708 (2021).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"556_CR5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.parkreldis.2019.05.012","volume":"64","author":"C Uribe","year":"2019","unstructured":"Uribe, C. et al. Progression of Parkinson\u2019s disease patients\u2019 subtypes based on cortical thinning: 4-year follow-up. Parkinsonism Relat. Disord. 64, 286\u2013292 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"556_CR6","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1001\/jamaneurol.2021.1312","volume":"78","author":"T Mitchell","year":"2021","unstructured":"Mitchell, T. et al. Emerging neuroimaging biomarkers across disease stage in Parkinson disease: a review. JAMA Neurol. 78, 1262\u20131272 (2021).","journal-title":"JAMA Neurol."},{"key":"556_CR7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2018.4377","volume":"76","author":"E De Pablo-Fern\u00e1ndez","year":"2019","unstructured":"De Pablo-Fern\u00e1ndez, E., Lees, A. J., Holton, J. L. & Warner, T. T. Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease. JAMA Neurol. 76, 470\u2013479 (2019).","journal-title":"JAMA Neurol."},{"key":"556_CR8","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1002\/hbm.25110","volume":"41","author":"T Guo","year":"2020","unstructured":"Guo, T. et al. Clinically relevant connectivity features define three subtypes of Parkinson\u2019s disease patients. Hum. Brain Mapp. 41, 4077\u20134092 (2020).","journal-title":"Hum. Brain Mapp."},{"key":"556_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.parkreldis.2020.11.010","volume":"82","author":"A Inguanzo","year":"2021","unstructured":"Inguanzo, A. et al. Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 82, 16\u201323 (2021).","journal-title":"Parkinsonism Relat. Disord."},{"key":"556_CR10","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/brain\/awx118","volume":"140","author":"SM Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad, S. M., Zeighami, Y., Dagher, A. & Postuma, R. B. Clinical criteria for subtyping Parkinson\u2019s disease: biomarkers and longitudinal progression. Brain 140, 1959\u20131976 (2017).","journal-title":"Brain"},{"key":"556_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37545-z","volume":"9","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Data-driven subtyping of Parkinson\u2019s disease using longitudinal clinical records: a cohort study. Sci. Rep. 9, 797 (2019).","journal-title":"Sci. Rep."},{"key":"556_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/JPD-202472","volume":"11","author":"TA Mestre","year":"2021","unstructured":"Mestre, T. A. et al. Parkinson\u2019s disease subtypes: critical appraisal and recommendations. J. Parkinsons Dis. 11, 395\u2013404 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"556_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03118-w","volume":"11","author":"F Rodriguez-Sanchez","year":"2021","unstructured":"Rodriguez-Sanchez, F. et al. Identifying Parkinson\u2019s disease subtypes with motor and non-motor symptoms via model-based multi-partition clustering. Sci. Rep. 11, 23645 (2021).","journal-title":"Sci. Rep."},{"key":"556_CR14","doi-asserted-by":"publisher","first-page":"e1445","DOI":"10.1212\/WNL.0000000000010498","volume":"95","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. Association of specific biotypes in patients with Parkinson disease and disease progression. Neurology 95, e1445\u2013e1460 (2020).","journal-title":"Neurology"},{"key":"556_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05892-0","volume":"9","author":"AL Young","year":"2018","unstructured":"Young, A. L. & Marinescu, R. V. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nat. Commun. 9, 4273 (2018).","journal-title":"Nat. Commun."},{"key":"556_CR16","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","volume":"27","author":"JW Vogel","year":"2021","unstructured":"Vogel, J. W., Young, A. L. & Oxtoby, N. P. Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease. Nat. Med. 27, 871\u2013881 (2021).","journal-title":"Nat. Med."},{"key":"556_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.parkreldis.2018.07.009","volume":"56","author":"TA Mestre","year":"2018","unstructured":"Mestre, T. A. et al. Reproducibility of data-driven Parkinson\u2019s disease subtypes for clinical research. Parkinsonism Relat. Disord. 56, 102\u2013106 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"556_CR18","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.3233\/JPD-191721","volume":"9","author":"P Borghammer","year":"2019","unstructured":"Borghammer, P. & Van Den Berge, N. Brain-first versus gut-first Parkinson\u2019s disease: a hypothesis. J. Parkinsons Dis. 9, S281\u2013s295 (2019).","journal-title":"J. Parkinsons Dis."},{"key":"556_CR19","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager, J. et al. Brain-first versus body-first Parkinson\u2019s disease: a multimodal imaging case-control study. Brain 143, 3077\u20133088 (2020).","journal-title":"Brain"},{"key":"556_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41531-022-00436-2","volume":"8","author":"P Borghammer","year":"2022","unstructured":"Borghammer, P. et al. A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson\u2019s disease. NPJ Parkinson\u2019s Dis. 8, 166 (2022).","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"556_CR21","doi-asserted-by":"publisher","first-page":"e1692","DOI":"10.1212\/WNL.0000000000200148","volume":"98","author":"LE Collij","year":"2022","unstructured":"Collij, L. E. et al. Spatial-temporal patterns of \u03b2-amyloid accumulation: a subtype and stage inference model analysis. Neurology 98, e1692\u2013e1703 (2022).","journal-title":"Neurology"},{"key":"556_CR22","doi-asserted-by":"publisher","first-page":"e941","DOI":"10.1212\/WNL.0000000000012410","volume":"97","author":"AL Young","year":"2021","unstructured":"Young, A. L. et al. Characterizing the clinical features and atrophy patterns of MAPT-related frontotemporal dementia with disease progression modeling. Neurology 97, e941\u2013e952 (2021).","journal-title":"Neurology"},{"key":"556_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22265-2","volume":"12","author":"A Eshaghi","year":"2021","unstructured":"Eshaghi, A., Young, A. L. & Wijeratne, P. A. Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data. Nat. Commun. 12, 2078 (2021).","journal-title":"Nat. Commun."},{"key":"556_CR24","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/brain\/awaa461","volume":"144","author":"NP Oxtoby","year":"2021","unstructured":"Oxtoby, N. P. et al. Sequence of clinical and neurodegeneration events in Parkinson\u2019s disease progression. Brain 144, 975\u2013988 (2021).","journal-title":"Brain"},{"key":"556_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"556_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak, H., Ghebremedhin, E., R\u00fcb, U., Bratzke, H. & Del Tredici, K. Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res. 318, 121\u2013134 (2004).","journal-title":"Cell Tissue Res."},{"key":"556_CR27","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.27802","volume":"34","author":"S Heinzel","year":"2019","unstructured":"Heinzel, S. et al. Update of the MDS research criteria for prodromal Parkinson\u2019s disease. Mov. Disord. Off. J. Mov. Disord. Soc. 34, 1464\u20131470 (2019).","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"556_CR28","doi-asserted-by":"publisher","first-page":"e460","DOI":"10.1212\/WNL.0000000000011155","volume":"96","author":"N Pyatigorskaya","year":"2021","unstructured":"Pyatigorskaya, N. et al. Parkinson disease propagation using MRI biomarkers and partial least squares path modeling. Neurology 96, e460\u2013e471 (2021).","journal-title":"Neurology"},{"key":"556_CR29","doi-asserted-by":"publisher","unstructured":"Horsager, J., Knudsen, K. & Sommerauer, M. Clinical and imaging evidence of brain-first and body-first Parkinson\u2019s disease. Neurobiol. Dis. 105626 https:\/\/doi.org\/10.1016\/j.nbd.2022.105626 (2022).","DOI":"10.1016\/j.nbd.2022.105626"},{"key":"556_CR30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00401-019-02071-3","volume":"138","author":"A Raunio","year":"2019","unstructured":"Raunio, A. et al. Lewy-related pathology exhibits two anatomically and genetically distinct progression patterns: a population-based study of Finns aged 85. Acta Neuropathol. 138, 771\u2013782 (2019).","journal-title":"Acta Neuropathol."},{"key":"556_CR31","doi-asserted-by":"publisher","first-page":"105557","DOI":"10.1016\/j.nbd.2021.105557","volume":"161","author":"P Borghammer","year":"2021","unstructured":"Borghammer, P. et al. Neuropathological evidence of body-first vs. brain-first Lewy body disease. Neurobiol. Dis. 161, 105557 (2021).","journal-title":"Neurobiol. Dis."},{"key":"556_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","volume":"115","author":"G Halliday","year":"2008","unstructured":"Halliday, G., Hely, M., Reid, W. & Morris, J. The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease. Acta Neuropathol. 115, 409\u2013415 (2008).","journal-title":"Acta Neuropathol."},{"key":"556_CR33","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","volume":"72","author":"SM Fereshtehnejad","year":"2015","unstructured":"Fereshtehnejad, S. M. et al. New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol. 72, 863\u2013873 (2015).","journal-title":"JAMA Neurol."},{"key":"556_CR34","doi-asserted-by":"publisher","first-page":"e894","DOI":"10.1212\/WNL.0000000000006134","volume":"91","author":"G Pagano","year":"2018","unstructured":"Pagano, G. et al. REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease. Neurology 91, e894\u2013e905 (2018).","journal-title":"Neurology"},{"key":"556_CR35","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3233\/JPD-212720","volume":"11","author":"C Zhou","year":"2021","unstructured":"Zhou, C. et al. Locus coeruleus degeneration correlated with levodopa resistance in parkinson\u2019s disease: a retrospective analysis. J. Parkinsons Dis. 11, 1631\u20131640 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"556_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbr.2014.05.009","volume":"270","author":"CY Ostock","year":"2014","unstructured":"Ostock, C. Y., Lindenbach, D., Goldenberg, A. A., Kampton, E. & Bishop, C. Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to L-DOPA in the hemi-parkinsonian rat. Behav. Brain Res 270, 75\u201385 (2014).","journal-title":"Behav. Brain Res"},{"key":"556_CR37","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1109\/TMI.2021.3134496","volume":"41","author":"Y Qiao","year":"2022","unstructured":"Qiao, Y. & Shi, Y. Unsupervised deep learning for FOD-based susceptibility distortion correction in diffusion MRI. IEEE Trans. Med. Imaging 41, 1165\u20131175 (2022).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"556_CR38","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1002\/mrm.28599","volume":"85","author":"M Golub","year":"2021","unstructured":"Golub, M., Neto Henriques, R. & Gouveia Nunes, R. Free-water DTI estimates from single b-value data might seem plausible but must be interpreted with care. Magn. Reson. Med. 85, 2537\u20132551 (2021).","journal-title":"Magn. Reson. Med."},{"key":"556_CR39","doi-asserted-by":"publisher","first-page":"613261","DOI":"10.3389\/frai.2021.613261","volume":"4","author":"AL Young","year":"2021","unstructured":"Young, A. L. et al. Ordinal SuStaIn: subtype and stage inference for clinical scores, visual ratings, and other ordinal data. Front. Artif. Intell. 4, 613261 (2021).","journal-title":"Front. Artif. Intell."},{"key":"556_CR40","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1093\/brain\/awz261","volume":"142","author":"MF Dirkx","year":"2019","unstructured":"Dirkx, M. F. et al. Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson\u2019s tremor. Brain 142, 3144\u20133157 (2019).","journal-title":"Brain"},{"key":"556_CR41","doi-asserted-by":"publisher","first-page":"102873","DOI":"10.1016\/j.nicl.2021.102873","volume":"32","author":"C Zhou","year":"2021","unstructured":"Zhou, C. et al. Locus coeruleus degeneration is associated with disorganized functional topology in Parkinson\u2019s disease. NeuroImage. Clin. 32, 102873 (2021).","journal-title":"NeuroImage. Clin."},{"key":"556_CR42","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/brain\/awx146","volume":"140","author":"RG Burciu","year":"2017","unstructured":"Burciu, R. G. et al. Progression marker of Parkinson\u2019s disease: a 4-year multi-site imaging study. Brain 140, 2183\u20132192 (2017).","journal-title":"Brain"},{"key":"556_CR43","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1093\/brain\/awr307","volume":"134","author":"Y Wang","year":"2011","unstructured":"Wang, Y. et al. Quantification of increased cellularity during inflammatory demyelination. Brain 134, 3590\u20133601 (2011).","journal-title":"Brain"},{"key":"556_CR44","doi-asserted-by":"publisher","unstructured":"Andica, C. et al. Free-water imaging in white and gray matter in Parkinson\u2019s disease. Cells 8 https:\/\/doi.org\/10.3390\/cells8080839 (2019).","DOI":"10.3390\/cells8080839"},{"key":"556_CR45","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.neuroimage.2015.10.019","volume":"125","author":"JLR Andersson","year":"2016","unstructured":"Andersson, J. L. R. & Sotiropoulos, S. N. An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging. Neuroimage 125, 1063\u20131078 (2016).","journal-title":"Neuroimage"},{"key":"556_CR46","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1093\/brain\/awab039","volume":"144","author":"L Zhou","year":"2021","unstructured":"Zhou, L. et al. Increased free water in the substantia nigra in idiopathic REM sleep behaviour disorder. Brain 144, 1488\u20131497 (2021).","journal-title":"Brain"},{"key":"556_CR47","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/0306-4522(83)90108-2","volume":"10","author":"MM Mesulam","year":"1983","unstructured":"Mesulam, M. M., Mufson, E. J., Wainer, B. H. & Levey, A. I. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 10, 1185\u20131201 (1983).","journal-title":"Neuroscience"},{"key":"556_CR48","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1002\/mds.29172","volume":"37","author":"M Banwinkler","year":"2022","unstructured":"Banwinkler, M., Dzialas, V., Hoenig, M. C. & van Eimeren, T. Gray matter volume loss in proposed brain-first and body-first Parkinson\u2019s disease subtypes. Mov. Disord. 37, 2066\u20132074 (2022).","journal-title":"Mov. Disord."},{"key":"556_CR49","doi-asserted-by":"publisher","unstructured":"Aksman, L. M. et al. pySuStaIn: a Python implementation of the subtype and stage inference algorithm. SoftwareX 16 https:\/\/doi.org\/10.1016\/j.softx.2021.100811 (2021).","DOI":"10.1016\/j.softx.2021.100811"},{"key":"556_CR50","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"DJ Kenneth Marek","year":"2011","unstructured":"Kenneth Marek, D. J. & Lasch, S. The Parkinson progression marker initiative (PPMI). Prog. Neurobiol. 95, 629\u2013635 (2011).","journal-title":"Prog. Neurobiol."},{"key":"556_CR51","doi-asserted-by":"publisher","first-page":"116189","DOI":"10.1016\/j.neuroimage.2019.116189","volume":"206","author":"ET Rolls","year":"2020","unstructured":"Rolls, E. T., Huang, C. C., Lin, C. P., Feng, J. & Joliot, M. Automated anatomical labelling atlas 3. Neuroimage 206, 116189 (2020).","journal-title":"Neuroimage"},{"key":"556_CR52","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.neuroimage.2009.06.012","volume":"47","author":"NI Keren","year":"2009","unstructured":"Keren, N. I., Lozar, C. T., Harris, K. C., Morgan, P. S. & Eckert, M. A. In vivo mapping of the human locus coeruleus. Neuroimage 47, 1261\u20131267 (2009).","journal-title":"Neuroimage"},{"key":"556_CR53","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1007\/s00415-023-11594-5","volume":"270","author":"Y Qin","year":"2023","unstructured":"Qin, Y. et al. Neuroimaging uncovers distinct relationships of glymphatic dysfunction and motor symptoms in Parkinson\u2019s disease. J. Neurol. 270, 2649\u20132658 (2023).","journal-title":"J. Neurol."},{"key":"556_CR54","first-page":"100151","volume":"7","author":"R Taniuchi","year":"2022","unstructured":"Taniuchi, R. et al. The power of instruction on retropulsion: a pilot randomized controlled trial of therapeutic exercise focused on ankle joint movement in Parkinson\u2019s disease. Clin. Park Relat. Disord. 7, 100151 (2022).","journal-title":"Clin. Park Relat. Disord."},{"key":"556_CR55","doi-asserted-by":"publisher","unstructured":"Wang, L. et al. Association of cortical and subcortical microstructure with clinical progression and fluid biomarkers in patients with Parkinson disease. Neurology https:\/\/doi.org\/10.1212\/wnl.0000000000207408 (2023).","DOI":"10.1212\/wnl.0000000000207408"},{"key":"556_CR56","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/cns.13188","volume":"26","author":"C Zhou","year":"2020","unstructured":"Zhou, C. et al. Progressive brain atrophy in Parkinson\u2019s disease patients who convert to mild cognitive impairment. CNS Neurosci. Ther. 26, 117\u2013125 (2020).","journal-title":"CNS Neurosci. Ther."},{"key":"556_CR57","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/mds.27989","volume":"35","author":"T Simuni","year":"2020","unstructured":"Simuni, T. et al. Clinical and dopamine transporter imaging characteristics of leucine rich repeat kinase 2 (LRRK2) and glucosylceramidase beta (GBA) Parkinson\u2019s disease participants in the Parkinson\u2019s progression markers initiative: a cross-sectional study. Mov. Disord. 35, 833\u2013844 (2020).","journal-title":"Mov. Disord."},{"key":"556_CR58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/mds.26374","volume":"31","author":"MA Nalls","year":"2016","unstructured":"Nalls, M. A. et al. Baseline genetic associations in the Parkinson\u2019s Progression Markers Initiative (PPMI). Mov. Disord. 31, 79\u201385 (2016).","journal-title":"Mov. Disord."},{"key":"556_CR59","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3233\/JPD-191860","volume":"10","author":"C Koros","year":"2020","unstructured":"Koros, C. et al. Serum uric acid level as a biomarker in idiopathic and genetic (p.A53T alpha-synuclein carriers) Parkinson\u2019s disease: data from the PPMI study. J. Parkinsons Dis. 10, 481\u2013487 (2020).","journal-title":"J. Parkinsons Dis."}],"updated-by":[{"DOI":"10.1038\/s41531-024-00635-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000}}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00556-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00556-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00556-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T03:05:13Z","timestamp":1705460713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00556-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["556"],"URL":"https:\/\/doi.org\/10.1038\/s41531-023-00556-3","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"assertion":[{"value":"22 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41531-024-00635-z","URL":"https:\/\/doi.org\/10.1038\/s41531-024-00635-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}